Patients with systemic lupus erythematosus (SLE) frequently show symptoms of central
nervous system (CNS) involvement, termed neuropsychiatric SLE (NPSLE). The CNS …

Patients with systemic lupus erythematosus (SLE) experience neuropsychiatric symptoms.
The term neuropsychiatric SLE (NPSLE) is a generic term that refers to a series of …

Autoimmune diseases are a group of disorders resulting from an alteration of immune
tolerance, characterized by the formation of autoantibodies and the consequent …

The neuropsychiatric involvement in systemic lupus erythematosus (NPSLE) is a challenge
for clinicians, both at a diagnostic and therapeutic level. Although in 1999 the American …

Neuropsychiatric (NP) events occur in the majority of patients with SLE and predominantly
affect the CNS in addition to the peripheral and autonomic systems. Approximately 30% of …

Lupus vasculitis (LV) is one of the secondary vasculitides occurring in the setting of systemic
lupus erythematosus (SLE) in approximately 50% of patients. It is most commonly …

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by
multiple immunologic abnormalities and has the potential to involve the central nervous …

Introduction The pathogenesis of neuropsychiatric systemic lupus erythematosus (NPSLE) is
widely unknown, and the role of autoantibodies is still undetermined. Methods To identify …

Choroid plexus (CP) enlargement is proposed as a marker of neuroinflammation in immune-
mediated conditions. CP involvement has also been hypothesized in the immunopathology …

Neurologic disorders are among the most common and important clinical manifestations
associated with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) …